Literature DB >> 25184053

Cancer incidence and mortality in the Greater Poland Region-Analysis of the year 2010 and future trends.

Agnieszka Dyzmann-Sroka1, Julian Malicki2.   

Abstract

BACKGROUND AND AIM: The Greater Poland Region is one of the most industrialised areas of Poland, with a high rate of cancer incidence and mortality. The present report estimated incidence and mortality data for Greater Poland in the year 2010.
METHODS: Statistical reports in this study include absolute number of cases and crude incidence rates. The derived age-, sex-, and site specific rates were age-standardised (ASRs per 100,000 person-years) using the European (ASRE) standard population.
RESULTS: In 2010, a total 13,581 new cancer cases were reported to the Greater Poland Cancer Registry. The number of new cases increased by 24% compared to 2001. Greater Poland has the second-highest ASR for both females and males among the 16 regions in Poland. The most common cancers are similar to those in other Western European countries. Among men, the most common cancers are lung (C34), colorectal (C18-C21), and prostate (C61) cancer. In women, breast cancer is the most common (C50), followed by colon (C18-C21) and lung (C34) cancer. Lung cancer in males accounts for more than one-third of all cancer-related deaths in Greater Poland. As in 2009, lung cancer is the leading cause of death in women.
CONCLUSIONS: Given the ageing of the population, the incidence of chronic diseases, including cancer, is expected to grow. These data indicate that cancer will continue to represent an important challenge both to local health authorities and the National Health Fund, which will need to meet the growing demand for cancer care.

Entities:  

Keywords:  Cancer; Epidemiology; Morbidity; Mortality

Year:  2014        PMID: 25184053      PMCID: PMC4150091          DOI: 10.1016/j.rpor.2014.04.001

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  9 in total

1.  The importance of accurate treatment planning, delivery, and dose verification.

Authors:  Julian Malicki
Journal:  Rep Pract Oncol Radiother       Date:  2012-03-06

2.  Investment in radiotherapy infrastructure positively affected the economic status of an oncology hospital.

Authors:  Mirella Smigielska; Piotr Milecki
Journal:  Rep Pract Oncol Radiother       Date:  2012-05-18

3.  Estimates of cancer incidence and mortality in Europe in 1995.

Authors:  F Bray; R Sankila; J Ferlay; D M Parkin
Journal:  Eur J Cancer       Date:  2002-01       Impact factor: 9.162

4.  The main challenges of Polish oncology.

Authors:  Krystyna Syczewska-Weber; Piotr Rucinski
Journal:  Public Health Rep       Date:  2008 Sep-Oct       Impact factor: 2.792

Review 5.  European perspective on the costs and cost-effectiveness of cancer therapies.

Authors:  Michael F Drummond; Anne R Mason
Journal:  J Clin Oncol       Date:  2007-01-10       Impact factor: 44.544

6.  Global cancer statistics.

Authors:  Ahmedin Jemal; Freddie Bray; Melissa M Center; Jacques Ferlay; Elizabeth Ward; David Forman
Journal:  CA Cancer J Clin       Date:  2011-02-04       Impact factor: 508.702

7.  Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.

Authors:  J Ferlay; E Steliarova-Foucher; J Lortet-Tieulent; S Rosso; J W W Coebergh; H Comber; D Forman; F Bray
Journal:  Eur J Cancer       Date:  2013-02-26       Impact factor: 9.162

8.  The development of nuclear medicine in Slovenia and Ljubljana; half a century of nuclear medicine in Slovenia.

Authors:  Zvonka Zupanic Slavec; Simona Gaberscek; Ksenija Slavec
Journal:  Radiol Oncol       Date:  2012-01-12       Impact factor: 2.991

9.  Long term outcome after combined modality treatment for anal cancer.

Authors:  Irena Oblak; Primoz Petric; Franc Anderluh; Vaneja Velenik; Peter Albert Fras
Journal:  Radiol Oncol       Date:  2012-04-11       Impact factor: 2.991

  9 in total
  12 in total

1.  Smoking during radiotherapy for head and neck cancer and acute mucosal reaction.

Authors:  Beata Szeszko; Karolina Osowiecka; Monika Rucińska; Ewa Wasilewska-Teśluk; Krzysztof Gliński; Lucyna Kępka
Journal:  Rep Pract Oncol Radiother       Date:  2015-05-23

2.  Leishmanial sphingolipid induces apoptosis in Sarcoma 180 cancer cells through regulation of tumour growth via angiogenic switchover.

Authors:  Subhadip Das; Nabanita Chatterjee; Dipayan Bose; Somenath Banerjee; Tarun Jha; Krishna Das Saha
Journal:  Tumour Biol       Date:  2014-12-19

Review 3.  What do women know about breast cancer prophylaxis and a healthy style of life?

Authors:  Jolanta Sielska; Monika Matecka; Eliza Dąbrowska; Ewa Jakubek; Monika Urbaniak
Journal:  Rep Pract Oncol Radiother       Date:  2015-07-29

4.  Challenges in organizing effective oncology service: inter-European variability in the example of head and neck cancers.

Authors:  Julian Malicki; Wojciech Golusinski
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-07-22       Impact factor: 2.503

5.  Basal cell carcinoma in farmers: an occupation group at high risk.

Authors:  Mateusz Szewczyk; Jakub Pazdrowski; Paweł Golusiński; Aleksandra Dańczak-Pazdrowska; Łukasz Łuczewski; Sławomir Marszałek; Ewa Majchrzak; Wojciech Golusiński
Journal:  Int Arch Occup Environ Health       Date:  2015-10-13       Impact factor: 3.015

6.  Can atopy have a protective effect against cancer?

Authors:  Andrzej Bożek; Jerzy Jarzab; Michal Mielnik; Agnieszka Bogacz; Renata Kozlowska; Dominika Mangold
Journal:  PLoS One       Date:  2020-02-03       Impact factor: 3.240

7.  Conformational and constitutional analysis of dental caries following radiotherapy for head and neck cancer.

Authors:  Joslei Carlos Bohn; Cassiano Lima Chaiben; Suzana Soares de Souza; Anelize Manuela Bahniuk Rumbelsperger; Ângela Fernandes; Maria Ângela Naval Machado; Thiago Gomes da Silva; Antonio Adilson Soares de Lima
Journal:  Rep Pract Oncol Radiother       Date:  2021-06-09

8.  Association between cancer and allergies.

Authors:  Renata Kozłowska; Andrzej Bożek; Jerzy Jarząb
Journal:  Allergy Asthma Clin Immunol       Date:  2016-08-11       Impact factor: 3.406

9.  Differential expression of mucin 1 and mucin 2 in colorectal cancer.

Authors:  Aldona Kasprzak; Elżbieta Siodła; Małgorzata Andrzejewska; Jacek Szmeja; Agnieszka Seraszek-Jaros; Szczepan Cofta; Witold Szaflarski
Journal:  World J Gastroenterol       Date:  2018-09-28       Impact factor: 5.742

10.  The Histochemical Alterations of Mucin in Colorectal Carcinoma Quantified by Two Efficient Algorithms of Digital Image Analysis.

Authors:  Aldona Kasprzak; Agnieszka Seraszek-Jaros; Joanna Jagielska; Celina Helak-Łapaj; Elżbieta Siodła; Jacek Szmeja; Elżbieta Kaczmarek
Journal:  Int J Mol Sci       Date:  2019-09-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.